Downloads provided by UsageCounts
This is Tim Willson's presentation at the monthly [virtual] Antiviral Drug Discovery (AViDD) Open Science Forum on 16 November 2022. His talk centers around the druggability of SARS-CoV-2 nsp13. HeliHub helicase database: Use SGC ChemBioPort Query ID: i9hao20220815 You can find a recording of his talk on the AViDD Open Science Forum Youtube page Tim Willson is a part of the Rapidly Emerging Antiviral Drug Development Initiative (READDI)
Antiviral Drug Discovery, AViDD, Rapidly Emerging Antiviral Drug Development Initiative (READDI), Open Science Forum, open science, Antiviral Drug Discovery Open Science Forum, Rapidly Emerging Antiviral Drug Development Initiative, READDI, AViDD Open Science Forum
Antiviral Drug Discovery, AViDD, Rapidly Emerging Antiviral Drug Development Initiative (READDI), Open Science Forum, open science, Antiviral Drug Discovery Open Science Forum, Rapidly Emerging Antiviral Drug Development Initiative, READDI, AViDD Open Science Forum
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
| views | 23 | |
| downloads | 22 |

Views provided by UsageCounts
Downloads provided by UsageCounts